Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avicenna Pharmaceutical Company is a leading Iranian pharmaceutical manufacturer and a key subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), the largest pharmaceutical holding in the region. Established in 1982 and headquartered in Tehran, the company specializes in the production of a diverse range of generic finished dosage forms, including tablets, capsules, and oral liquids. Its extensive portfolio covers critical therapeutic areas such as cardiovascular health, central nervous system disorders, and gastrointestinal diseases. Avicenna operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, enabling it to serve both the domestic Iranian market and various export destinations. The company plays a vital role in the regional healthcare supply chain through its large-scale production capabilities and ongoing commitment to pharmaceutical quality and accessibility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aviccena Pharmaceutical Company.